Get started
Author

Joe DePinto

Observed institution: McKesson (United States)
ORCID: 0009-0007-2378-7626
Observed ORCID: 0009-0007-2378-7626
OpenAlex ID: A5148766466
Bridging the gap in cell and gene therapy: addressing operational and financial barriers to achieve sustainable access.
2026 · Gary L Simmons, Robert E Richards, et al. · PubMed
Cell and gene therapies in managed care: US payer insights on coverage and financial risk
2026 · Elias C. Pittos, Joe DePinto · Figshare
Cell and gene therapies in managed care: US payer insights on coverage and financial risk
2026 · Elias C. Pittos, Joe DePinto · Journal of Medical Economics
PDF
Five-year durability in cell and gene therapy: evidence review and implications for payer coverage
2026 · Elias C. Pittos, Joe DePinto · Expert Review of Pharmacoeconomics & Outcomes Research
Real-World Barriers and Opportunities for Cell and Gene Therapy (CGT): An Analysis of US Hematologist and Oncologist Insights on Readiness and Access
2026 · Gary L. Simmons, Joe DePinto, et al. · Transplantation and Cellular Therapy
Works count: 5
Citation count:
H-index:
I10-index:
Year
Topic
Type